Insider trade

Ventas (VTR): CEO sold ~$20K

Debra A Cafaro, CEO at Ventas, sold ~$20K of Ventas shares.

~$20K
Approx. value · 264 sh @ $75.05
1.15M
Holds after · shares reported
Traded
Nov 6, 2025
Filed
Nov 6, 2025

What stands out in this filing

  • After this sale the filing reports 1,145,695 shares.
  • 264 shares at an average of $75.05 each, as reported on the form.
  • Footnote references a pre-arranged trading plan (Rule 10b5-1).

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Sep 15, 2025InsiderCEO sold ~$28K of VTR shares in the open market
  2. Sep 30, 2025InsiderCEO sold ~$143K of VTR shares in the open market
  3. Oct 1, 2025Insider · 2 peopleInsiders: 2 sales (~$904K)
  4. Oct 20, 2025Insider · 1 personInsiders: 2 sales (~$15.7M)
  5. Oct 29, 2025Company filing · Form 8-K · ResultsReported its results
  6. Oct 30, 2025Insider · 1 personInsiders: 4 sales (~$23.6M)
  7. Nov 3, 2025Insider · 1 personInsiders: 2 sales (~$1.5M)
  8. Nov 4, 2025Insider · 2 peopleInsiders: 2 sales (~$1.2M)
  9. Nov 5, 2025Insider · 2 peopleInsiders: 2 sales (~$1.5M)
  10. Nov 6, 2025 · this disclosureInsiderCEO sold ~$20K of VTR shares in the open market

What came next

  1. Nov 6, 2025InsiderCEO sold ~$12K of VTR shares in the open market
  2. Nov 7, 2025InsiderCEO sold ~$3K of VTR shares in the open market
  3. Nov 12, 2025InsiderCFO sold ~$2.58M of VTR shares in the open market
  4. Nov 12, 2025CongressDisclosed purchase of VTR — reported range $1,001 - $15,000
  5. Nov 14, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On November 17, 2025, Ventas, Inc. (the “Company”) announced that Peter J. Bulgarelli, Executive Vice President, Outpatient Medical & Research, Ventas, Inc. and President and CEO, Lillibridge Healthcare Services, Inc., is expected to retire effective as of May 1, 2026 (the “Effective Date”).”
  6. Nov 17, 2025InsiderCEO sold ~$3.26M of VTR shares in the open market
  7. Nov 18, 2025InsiderCEO sold ~$222K of VTR shares in the open market
  8. Nov 19, 2025InsiderCEO sold ~$179K of VTR shares in the open market
  9. Dec 1, 2025InsiderCEO sold ~$831K of VTR shares in the open market
  10. Jan 2, 2026Insider · 2 peopleInsiders: 2 sales (~$3.1M)
  11. Jan 7, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
  12. Jan 9, 2026CongressDisclosed partial sale of VTR — reported range $1,001 - $15,000
  13. Jan 21, 20265% stakeJPMORGAN CHASE & CO. reported a passive stake (13G) of 5.9%
  14. Feb 2, 2026InsiderCEO sold ~$802K of VTR shares in the open market
  15. Feb 5, 2026Company filing · Form 8-K · ResultsReported its results
  16. Feb 6, 2026InsiderCEO sold ~$849K of VTR shares in the open market
  17. Feb 11, 2026Insider · 5 days before an 8-KOfficer sold ~$3.02M of VTR shares in the open market
  18. Feb 16, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On February 16, 2026, Gregory R. Liebbe, Senior Vice President, Chief Accounting Officer and Controller informed Ventas, Inc. (the “Company”) that he is resigning to pursue other opportunities.”
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Ventas

OQRO holds no insider, Congress, fund or contract record for Ventas dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its VTR page.

Other recent filings by Debra A Cafaro, Chairman and CEO

The full history of Debra A Cafaro, Chairman and CEO is on the profile page.

How this filing works

Explore the data

Common questions

Which Ventas (VTR) insider traded, and how much?

Debra A Cafaro, CEO at Ventas, sold ~$20K of Ventas shares. 264 shares at $75.05.

When did it happen, and when was it made public?

Traded: Nov 6, 2025. Filed: Nov 6, 2025.

What stands out in this filing?

After this sale the filing reports 1,145,695 shares. 264 shares at an average of $75.05 each, as reported on the form. Footnote references a pre-arranged trading plan (Rule 10b5-1).

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

Does this mean VTR stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Ventas

Everything OQRO holds on this company is on its VTR page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data